The US Blood Transfusion Diagnostics Market

Effective Strategies for Vendors to Tackle the Decrease in Blood Supply Demand

INDUSTRY
Healthcare
SECTOR
Life Sciences

RELEASE DATE
10-Mar-2015
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
NE4E-01-00-00-00
SKU
LS00049-NA-MR_16890
Yes
SHARE

The US Blood Transfusion Diagnostics Market
Published on: 10-Mar-2015 | SKU: LS00049-NA-MR_16890

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

This research study focuses on diagnostic tests performed on blood donor samples. The market segments are divided by blood grouping and disease screening and cover manual and automated instruments as well as reagents used for Abo and Rh testing, RBC antigen, and antibody identification and detection. Disease screening includes both serological and molecular testing. Comprehensive reports on test volume and pricing analysis for donor serological tests, blood grouping, and molecular tests are provided. The market forecasts begin in 2015 and end in 2018 using a base year of 2014. Supplier market shares, extensive product analysis, and new market opportunities to tackle the decreasing demand for blood supply are discussed.

Key Findings

Key Findings (continued)

Scope and Segmentation

Market Segmentation

Key Questions This Study Will Answer

Market Engineering Measurements

CEO’s Perspective

Key Companies to Watch

Key Companies to Watch (continued)

Executive Summary—2 Big Predictions

Executive Summary—2 Big Predictions (continued)

Executive Summary—2 Big Predictions (continued)

Market Background

Market Background—Types of Blood Bank Analyzers

Market Background—Types of Blood Bank Analyzers (continued)

Market Background—Types of Blood Bank Analyzers (continued)

Comparison of Immunohematology Methods

Voice of Customer—Factors Governing Equipment Purchase for a Transfusion Laboratory

Voice of Customer

Market Segmentation

Procurement Process

Defining Future Healthcare Trends

New Market Opportunities

New Market Opportunities (continued)

Market Drivers

Market Restraints

Market Impact of Top 6 Trends

Market Engineering Measurements

Market Engineering Measurements (continued)

Factors Impacting Market Forecasts

Revenue Forecast

Revenue Forecast Discussion

Revenue Forecast

Revenue Forecast Discussion

Revenue Forecast Discussion (continued)

Test Volume for Abo, Rh, RBC Antigen Typing, Antibody Identification, and Screening

Medicare Expenditure for Abo, Rh, and RBC Antigen Typing

Test Volume and Pricing Analysis for Blood Grouping Tests

Test Volume and Pricing Analysis for Blood Grouping Tests (continued)

Medicare Expenditure for Antibody Screening, Identification, and Cross Matching

Revenue Forecast

Revenue Forecast for Serological and Molecular

Revenue Forecast Discussion

Revenue Forecast Discussion (continued)

Test Volume and Pricing Analysis for Disease Screening and NAT Tests

Test Volume Serological Donor Screening Tests

Test Volume Serological Donor Screening Tests (continued)

Cost Comparison per Test for Serological and NAT

Most Frequently Ordered Blood Tests by Rank

Accredited Immunohematology Reference Laboratories

Accredited Immunohematology Reference Laboratories (continued)

Accredited Immunohematology Reference Laboratories (continued)

Accredited Immunohematology Reference Laboratories (continued)

Accredited Immunohematology Reference Laboratories (continued)

Blood Transfusion Centers

Overview of Supply Chain in Blood Banks

Overview of Supply Chain in Blood Banks (continued)

Problem Areas and Solution

Market Share

Market Share Analysis

Product Analysis Blood Grouping

Product Analysis Blood Grouping (continued)

Product Analysis Disease Screening (Serological and Molecular)

Product Analysis Disease Screening (Molecular Assays)

Merger, Acquisition, and Partnership Assessment

Merger, Acquisition, and Partnership Assessment (continued)

Merger, Acquisition, and Partnership Assessment (continued)

Merger, Acquisition, and Partnership Assessment (continued)

Immucor

Ortho Clinical Diagnostics

Beckman Coulter (Danaher)

BioRad

Quotient Limited (previously known as Alba Bioscience)

Immucor

Diagast

3Ti (Transfusion & Transplantation Technologies)

The Last Word—2 Big Predictions

The Last Word—Discussion

The Last Word—Discussion (continued)

Legal Disclaimer

Drivers Explained

Drivers Explained (continued)

Restraints Explained

Restraints Explained (continued)

Restraints Explained (continued)

Restraints Explained (continued)

Restraints Explained (continued)

Additional Studies of Interest

Additional Studies of Interest (continued)

Market Engineering Methodology

Learn More—Next Steps

List of Exhibits

List of Exhibits (continued)

List of Exhibits (continued)

List of Exhibits (continued)


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This research study focuses on diagnostic tests performed on blood donor samples. The market segments are divided by blood grouping and disease screening and cover manual and automated instruments as well as reagents used for Abo and Rh testing, RBC antigen, and antibody identification and detection. Disease screening includes both serological and molecular testing. Comprehensive reports on test volume and pricing analysis for donor serological tests, blood grouping, and molecular tests are provided. The market forecasts begin in 2015 and end in 2018 using a base year of 2014. Supplier market shares, extensive product analysis, and new market opportunities to tackle the decreasing demand for blood supply are discussed.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Divyaa Ravishankar
WIP Number NE4E-01-00-00-00
Is Prebook No

The US Blood Transfusion Diagnostics Market

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
LS00049-NA-MR_16890